Enterprise Value
94.97M
Cash
113M
Avg Qtr Burn
-25.11M
Short % of Float
9.69%
Insider Ownership
1.97%
Institutional Own.
91.49%
Qtr Updated
06/30/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|---|---|
OTX-2002 Details Cancer, Hepatocellular carcinoma, Liver cancer | Phase 1/2 Data readout |